Must know information
for a sharp and resilient brain
"The amazing brain is finally getting the attention it deserves.
Contact me for personal instruction or to book an advantageous presentation for your company."
The Brain Health Website for Optimal Aging
Pat Faust, MGS, CAt
Welcome and thanks for visiting my site! Optimal aging doesn't need to be wishful thinking - it is remarkably attainable - if you know the path to ultimate brain health. And I can help you. That's
why I'm here. Hopefully you are here for the same reason. See for yourself!
Finally, Your Personal Coach for an Ageless Brain
I HELP PEOPLE LEARN HOW TO PREVENT ALZHEIMER'S IN THEIR LIFE
While it is true that:
· Our brain can change;
· We can recover aging losses;
· We can prevent Alzheimer’s disease;
It requires dedication and consistency in living a healthy
brain lifestyle to actually change your brain.
What I have found is that even though most people want these positive brain changes – it is an overwhelming process that is beyond their reach.
That is why I am personally going to be Your Ageless Brain Coach.
And because everyone’s brain is different, I will customize these steps to maximize your
Along the way, we will work on habits and changes; goal setting; memory strategies; organization; emotions and their role in chronic disease.
Since Alzheimer's disease is epidemic, experts around the world are touting the benefit of living a brain- healthy lifestyle. 1 in 6 of us are going to get Alzheimer's disease. Do you want to take the chance that
you will be the one? I can cut that risk. Contact Me!
This month happens to be Alzheimer’s and Brain Awareness Month. The FDA made it a month to remember! The drug aducanumab – marketed as Aduhelm – received approval from the FDA for release. Aduhelm is an infusion therapy meant for Alzheimer’s related Mild Cognitive impairment, and early stages of Alzheimer’s disease. It is a treatment that focuses on the removal of amyloid plaques that occur in the development of the disease. It has the potential to change the underlying disease process in AD.
The FDA gave approval with a caveat: they want more studies done on the drug to support the approval. There was some concern over the effectiveness and some side effects of the drug. In two separate trials that administered protocols the same way to participants that were comparable – there were two different end results. One of the trials showed success in decreasing amyloid plaques which resulted in better memory and executive control function. The other group showed very different results.
Because the FDA believed that the study results were inconclusive, they approved the drug with the stipulation that more studies would be conducted. They considered the drug to be critically important to those with MCI and early-stage AD. If they delayed approval until more conclusive studies were done, those in the early stages of the disease would continue to decline and fall out of the acceptable criteria for receiving the drug. If the studies don’t show positive results, the FDA could pull the drug from the market.
The Alzheimer’s Association is celebrating this new drug. It has been over twenty years since a viable drug was brought to market. There are a couple of barriers to receiving Aduhelm. Delivery of the drug to a patient is by infusion. That complicates the process of getting it out equitably to all those with early AD. The price tag on this drug is $56,000. Per year. The Alzheimer’s Association is aware of these barriers and is working with Biogen and CMS – the Center for Medicare and Medicaid – to make it more affordable and more widely available. To be clear – this is not a cure. But it is a foot in the door to find a cure.
I was on a live announcement about Aduhelm last night. There was high praise to all involved within the organization that worked so hard to make this day happen. As it turns out, the Alzheimer’s Association is the largest research entity in the world. There is a combination of funding sources to make this happen. The Alzheimer’s Association has a strong presence in Washington D.C. to lobby for funds for research. But the grassroots efforts of funding raising have been immensely successful. Donations come from large donors and sponsors. And donations come from year-round fundraising events. I have talked about the Walk to End Alzheimer’s for the last few years and I have been involved through my team – My Boomer Brain. I am starting my fundraising campaign today. The momentum has shifted. Now that researchers have brought a viable drug to market, they will continue to expand their studies because this victory has shown it is possible to treat Alzheimer’s.
To be a part of history, go to www.act.alz.org and click on Find a Team. Again, we are team My Boomer Brain. You can find my site through the team name or my name: Patricia Faust. You can join team My Boomer Brain and be involved in your own fundraising efforts. There are many incentives to raise funds. For example, a 100. Donation gives you a 2021 Walk to End Alzheimer’s t-shirt. The incentives increase with each benchmark donation. Or you can donate to this critical cause. Your donation of any amount will support research to ultimately find the first survivor.
Thanks for being a part of My Boomer Brain.